Cargando…
The Role of Immune Checkpoint Blockade in the Hepatocellular Carcinoma: A Review of Clinical Trials
The prevalence of primary liver cancer is rapidly rising all around the world. Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer. Unfortunately, the traditional treatment methods to cure HCC showed poor efficacy in patients who are not candidates for liver transplantatio...
Autores principales: | Ozer, Muhammet, George, Andrew, Goksu, Suleyman Yasin, George, Thomas J., Sahin, Ilyas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692256/ https://www.ncbi.nlm.nih.gov/pubmed/34956912 http://dx.doi.org/10.3389/fonc.2021.801379 |
Ejemplares similares
-
Adoptive Cell Therapy in Hepatocellular Carcinoma: A Review of Clinical Trials
por: Ozer, Muhammet, et al.
Publicado: (2023) -
Immune Checkpoint Blockade Therapy for Hepatocellular Carcinoma: Clinical Challenges and Considerations
por: Zhang, Qi, et al.
Publicado: (2020) -
Immune Checkpoint Blockade in Chinese Patients With Hepatocellular Carcinoma: Characteristics and Particularity
por: Wu, Yaoqiang, et al.
Publicado: (2022) -
Effects of Clinical and Tumor Characteristics on Survival in Patients with Hepatocellular Carcinoma with Bone Metastasis
por: Ozer, Muhammet, et al.
Publicado: (2023) -
Lactobacillus acidophilus-Induced Endocarditis and Associated Splenic Abscess
por: Ozer, Muhammet, et al.
Publicado: (2020)